Insider Trends: Insider at AbbVie Receives Stock Award, Does not Sell, Slowing 90-Day Selling Trend
05:08 PM EDT, 05/11/2021 (MT Newswires) -- Dr Robert J Alpern, Director, May 07, 2021, was awarded 1,681 AbbVie (ABBV) shares which translated into approximately $195,366 based on the daily closing price. Subsequent to the Form 4 filing with the SEC, Dr Alpern owns 30,121 company shares, with a market value, based on the prior-day closing price, of $3.50 million.
Over the last 90 days, previous to the date of this filing, there have been 23 insider transactions reported to the SEC for AbbVie. These transactions came from the activities of 12 individual insiders that resulted in a net disposition of 271,505 company shares. In the preceding 90-day window of time, there were 13 transactions from 5 insiders and resulted in the net disposition of 44,367 shares.
This is a lower level of transactions than the peer group average in the 22-company Proprietary & Advanced Pharmaceuticals peer group over the last 90-day period. Peer group activity averaged 64.0 transactions per company, with company insiders acquiring on average 330,707 shares.
SEC Story Link http://www.sec.gov/Archives/edgar/data/1551152/000117911021005197/xslF345X03/edgar.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.